+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990576
The global human liver model market size was estimated at USD 1.19 billion in 2023 and is projected to grow at a CAGR of 13.8% from 2024 to 2030. The market is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected to propel its growth.

According to the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set to transform healthcare by addressing organ shortages and improving patient care globally.

The prevalence of liver diseases is on the rise globally, leading to a growing demand for advanced research tools include Human Liver Model. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due to factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient Human Liver Model to support research and drug development efforts.

Organ 3D printing technologies have advanced significantly recently, particularly in developing Human Liver Model. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Diego made significant progress in addressing challenging issues in bio printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.

Global Human Liver Model Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global human liver model market report based on product, application, end-use, and region:
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • 2D Models
  • Cell lines
  • Primary Cells
  • 3D Models
  • Liver on Chip
  • Organoids
  • Spheroids
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • ADME Studies
  • Toxicology Testing
  • Disease Modelling
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Human Liver Model Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of liver diseases
3.2.1.2. Advancements in organ printing technologies
3.2.1.3. Increased demand for therapeutic drugs for liver cancer
3.2.2. Market restraint analysis
3.2.2.1. High costs and complexity associated with maintaining Human Liver Model
3.3. Human Liver Model Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Human Liver Model Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Global Human Liver Model Market Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. 2D Models
4.4.1. 2D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Cell Lines
4.4.2.1. Cell Lines market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Primary Cells
4.4.3.1. Primary Cells market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. 3D Models
4.5.1. 3D models market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Liver on Chip
4.5.2.1. Liver on Chip market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Organoids
4.5.3.1. Organoids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Spheroids
4.5.4.1. Spheroids market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Human Liver Model Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Global Human Liver Model Market Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. ADME Studies
5.4.1. ADME Studies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Toxicology Testing
5.5.1. Toxicology Testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Disease Modelling
5.6.1. Disease Modelling market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Human Liver Model Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Global Human Liver Model Market End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Global Human Liver Model Market Size and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Academic & Research Institutes
6.4.1. Academic & Research Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Pharmaceutical & Bioproduct Companies
6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract Research Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Human Liver Model Market: Regional Estimates & Trend Analysis
7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
7.2. Regional Market Dashboard
7.3. Regional Market Share Analysis, 2023 & 2030
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. ATCC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AcceGen
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. ZenBio, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Organovo Holdings Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. BioIVT
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. InSphero
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Emulate, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Mimetas
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. CN Bio Innovations Ltd
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 3 Global Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 4 Global Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 5 Global Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 6 North America Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 7 North America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 8 North America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 9 North America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 24 Germany Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 25 Germany Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 26 UK Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 27 UK Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 28 UK Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 29 France Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 30 France Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 31 France Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 45 Norway Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Human Liver Model market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 51 China Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 52 China Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 53 China Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 55 Japan Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 56 Japan Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 57 India Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 58 India Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 59 India Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 64 Australia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 65 Australia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 70 Latin America Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 71 Latin America Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 72 Brazil Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 73 Brazil Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 74 Brazil Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 75 Argentina Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 76 Argentina Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 77 Argentina Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 78 MEA Human Liver Model market, by region, 2018 - 2030 (USD Million)
Table 79 MEA Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 80 MEA Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 81 MEA Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 82 South Africa Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 83 South Africa Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 84 South Africa Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 88 UAE Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 89 UAE Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 90 UAE Human Liver Model market, by end use, 2018 - 2030 (USD Million)
Table 91 Kuwait Human Liver Model market, by product, 2018 - 2030 (USD Million)
Table 92 Kuwait Human Liver Model market, by application, 2018 - 2030 (USD Million)
Table 93 Kuwait Human Liver Model market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Parent market outlook
Fig. 9 Related/ancillary market outlook
Fig. 10 Human Liver Model market driver impact
Fig. 11 Human Liver Model market restraint impact
Fig. 12 Human Liver Model market: Product movement analysis
Fig. 13 Human Liver Model market: Product outlook and key takeaways
Fig. 14 2D models market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Cell lines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Primary cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 3D models market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Liver on chip market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Organoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Spheroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Human Liver Model market: Application movement analysis
Fig. 23 Human Liver Model market: Application outlook and key takeaways
Fig. 24 ADME studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Disease modelling market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Human Liver Model market: End Use movement analysis
Fig. 29 Human Liver Model market: End Use outlook and key takeaways
Fig. 30 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Pharmaceutical & bioproduct companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 32 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Global Human Liver Model market: Regional movement analysis
Fig. 34 Global Human Liver Model market: Regional outlook and key takeaways
Fig. 35 Global Human Liver Model market share and leading players
Fig. 36 North America
Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. key country dynamics
Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Canada key country dynamics
Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Mexico key country dynamics
Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe
Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK key country dynamics
Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany key country dynamics
Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 France key country dynamics
Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy key country dynamics
Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Spain key country dynamics
Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Denmark key country dynamics
Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Sweden key country dynamics
Fig. 59 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Norway key country dynamics
Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific
Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 China key country dynamics
Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Japan key country dynamics
Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 India key country dynamics
Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Australia key country dynamics
Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 South Korea key country dynamics
Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Thailand key country dynamics
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Latin America
Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Brazil key country dynamics
Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Argentina key country dynamics
Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Middle East and Africa
Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 South Africa key country dynamics
Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Saudi Arabia key country dynamics
Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 UAE key country dynamics
Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Kuwait key country dynamics
Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • ATCC
  • Merck KGaA
  • AcceGen
  • ZenBio, Inc.
  • Organovo Holdings Inc.
  • BioIVT
  • InSphero
  • Emulate, Inc.
  • Mimetas
  • CN Bio Innovations Ltd

Methodology

Loading
LOADING...

Table Information